MANILA - The Board of Investments (BOI) aims to attract more investments in the field of biotechnology as a Philippine delegation is meeting with healthcare innovators in the San Francisco Bay Area and Silicon Valley in a roadshow in the United States this week. The BOI, under its Make It Happen in the Philippines campaign, is doing a roadshow in Florida, San Francisco, and Los Angeles until Saturday to introduce opportunities in the country for US-based startups in the life sciences and healthcare space. DTI Undersecretary Rafaelita Aldaba is leading the delegation. Among the prominent startups that the delegation met during the roadshow include Filipino-led InterVenn Biosciences, Presidio Medical, and Vator. InterVenn, which was founded by Filipino Aldo Carrascoso, is pioneering the latest innovation in pre-cancer screening using artificial intelligence (AI). The company is further expanding its Philippine office, the hub for InterVenn's software, adding 100 software Filipino eng
endIndex: InterVenn Biosciences CEO and founder Aldo Carrascoso takes a closer look at one of their peripherals in the company s high-end Bay Area lab. Photo courtesy of INTERVENN BIOSCIENCES
The pandemic is a reminder, in the most painful way, that science and technology are essential to the survival of humanity. As a result, it renewed public interest in the biotech space, spawning a biotech boom, particularly in the United States.
One of the startups benefiting from this upsurge is Filipino-led InterVenn BioSciences, a biotech company headquartered in San Francisco. In November, it raised $34 million in Series B funding to commercialize the company’s precision medicine platform for ovarian cancer.